David S Jones is the Professor of Pharmaceutical and Biomaterial Engineering at Queen’s University Belfast, Northern Ireland. He gained a BSc, PhD and a DSc from Queen’s University of Belfast (QUB). From 1989–1992, he was a lecturer in Pharmaceutics at the University of Otago, and from 1992–1994, he held the position of Head of Formulations at Norbrook Industries Limited (Northern Ireland). In 1994, he was appointed to a lectureship at the School of Pharmacy, QUB, and was promoted to a Senior Lectureship in 1997. Since 1999, he has held a personal Chair at the School of Pharmacy, QUB. His research concerns the design, characterisation and engineering of pharmaceutical materials/dosage forms and biomedical devices. He is the author of three textbooks, 13 patents and >400 research papers/communications. He has been awarded five international awards for his research. He has been elected to the Royal Academy of Engineering (FREng), the Academy of Medical Sciences (FMedSci) and the Royal Irish Academy (MRIA), in addition to Fellowships from the Institute of Materials, Minerals and Mining, the Royal Statistical Society, the Royal Society of Chemistry, and the Irish Academy of Engineering. He co-founded Re-Vana Therapeutics, a spin-out company that provides controlled release of biologics from implants to treat sight-threatening ocular diseases. Most recently, he was awarded a Member of the Order of the British Empire (MBE) on the 2024 King’s Birthday Honours List.